Quince Therapeutics, Inc. - 8-K Filing
Quince Therapeutics directors June Bray, David Lamond and Christopher Senner tender conditional resignations effective after shareholder vote on three proposals; new directors Catherine Bonuccelli, Leone Patterson, James Valentine and Drayton Wise conditionally appointed. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $QNCX